Litcius/Paper detail

BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis

Kassandra Koumaki, Georgia Kontogianni, Vivian Kosmidou, Fani Pahitsa, Eftichia Kritsi, Maria I. Zervou, Aristotelis Chatziioannou, Vassilis L. Souliotis, Olga Papadodima, Alexander Pintzas

2020Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease36 citationsDOI

Topics & Concepts

Cancer researchCircuit breakerMedicineEngineeringMechanical engineeringMelanoma and MAPK PathwaysCytokine Signaling Pathways and InteractionsCancer Mechanisms and Therapy
BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis | Litcius